S&P Futures
3,831.75 -2.25 (-0.06%) Dow Futures
30,924.00 -12.00 (-0.04%) Nasdaq Futures
11,808.50 0.00 (0.00%) Russell 2000 Futures
1,739.60 -2.10 (-0.12%) Crude Oil
100.67 +1.17 (+1.18%) Gold
1,766.70 +2.80 (+0.16%)
Twist Bioscience Corporation (TWST)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 37.08 |
| Open | 36.79 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 35.92 - 41.20 |
| 52 Week Range | 25.07 - 139.99 |
| Volume | |
| Avg. Volume | 1,197,455 |
| Market Cap | 2.312B |
| Beta (5Y Monthly) | 1.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.72 |
| Earnings Date | Aug 04, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.83 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for TWST
Related Research
- Twist Bioscience CorporationAnalyst Report: Illumina IncIllumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions, government and commercial laboratories, and hospitals, as well as to pharmaceutical, biotech, agrigenomics, and consumer genomics businesses. The company's portfolio of products and services are designed to accelerate and simplify genetic analysis. The company also invests in startup companies that are pursuing promising genomic-related opportunities. It has roughly 9,100 full-time employees. ILMN shares are included in the S&P 500 index.RatingFair ValueEconomic Moat6 days agoArgus Research
- Business Wire
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea, June 30, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop antibodies for applications in immuno-oncology.
- Zacks
Twist Bioscience (TWST) Stock Jumps 7.7%: Will It Continue to Soar?
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Motley Fool
3 Stocks That Could Double by 2025
Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Twist Bioscience (NASDAQ: TWST). Prosper Junior Bakiny (Axsome Therapeutics): Investors intent on doubling their money by 2025 might benefit from looking at stocks that seem wildly undervalued and could experience multiple catalysts in the next couple of years. Axsome Therapeutics lagged the market in recent months, primarily because of regulatory roadblocks.
